Potency of opioid ligands to inhibit forskolin-stimulated adenylyl cyclase activity in CHO cells stably expressing μδ2S196L, μδ2μ 67S196L, μδ2μ7S196L, or μδ2 chimeric opioid receptors
The potency of opioid ligands to inhibit 10 μM forskolin-stimulated adenylyl cyclase activity was determined as described under Materials and Methods. Values represent average ± S.E.M. of at least three experiments.